M&T Bank’s Treace Medical Concepts TMCI Stock Holding History

M&T Bank’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,271	Closed	-$227K	–	1631
2021 Q2	$227K	Buy	+7,271	New	+$231K	﹤0.01%	1401

Other funds holding TMCI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

M&T Bank's TMCI Position: Q3 2021 in Review

M&T Bank sold out of Treace Medical Concepts (TMCI) in Q3 2021, closing a stake of 7,271 shares — an estimated $227K sold.

M&T Bank first reported a position in TMCI in Q2 2021 and held it in 1 quarter. The position peaked at $227K in Q2 2021. 62 funds tracked by Wall St. Rank hold TMCI as of Q3 2021.

M&T Bank reported no remaining Treace Medical Concepts position as of Q3 2021 after selling out during the quarter.
M&T Bank sold 7,271 Treace Medical Concepts shares in Q3 2021, an estimated $227K.
M&T Bank first reported a position in Treace Medical Concepts in Q2 2021 and held it in 1 quarter.
M&T Bank's Treace Medical Concepts position peaked at $227K in Q2 2021.
62 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2021.

Based on M&T Bank's 13F filing for Q3 2021, filed 28 Oct 2021.